These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 834952)
21. A preliminary investigation of the association between serum uric acid and impaired renal function. Chen YC; Su CT; Wang ST; Lee HD; Lin SY Chang Gung Med J; 2009; 32(1):66-71. PubMed ID: 19292941 [TBL] [Abstract][Full Text] [Related]
22. Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients. Cassel A; Leibovitz N; Hornstein L; Quitt M; Aghai E Exp Hematol; 1990 Dec; 18(11):1171-3. PubMed ID: 2226677 [TBL] [Abstract][Full Text] [Related]
24. J-shaped mortality relationship for uric acid in CKD. Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995 [TBL] [Abstract][Full Text] [Related]
25. [Prognostic factors in multiple myeloma]. Pick AI; Tamir R; Vana D; Duczyminer-Kahana M; Weiss H; Lurie H; Dawidowich J; Meyerson E; Gelernter I Harefuah; 1990 Apr; 118(8):437-42. PubMed ID: 2358224 [TBL] [Abstract][Full Text] [Related]
26. [Therapeutic application of sequential bone marrow biopsy in myeloma: analysis of 13 medullary biopsies]. Paule B; Médicis P; Clerc D; Bennet P; Bisson M; Massias P Biomed Pharmacother; 1986; 40(7):261-4. PubMed ID: 3814757 [TBL] [Abstract][Full Text] [Related]
27. High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment. Urbańska-Ryś H; Robak T Mediators Inflamm; 2003 Aug; 12(4):229-35. PubMed ID: 14514474 [TBL] [Abstract][Full Text] [Related]
28. Hereditary nephropathy associated with hyperuricemia and gout. Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538 [TBL] [Abstract][Full Text] [Related]
29. [Study of hyperuricemia in Tahiti. 31 cases hospitalized at the Territorial Hospital Center in Papeete (Tahiti)]. Prigent D; Spiegel A; Brodin S; Gras C Med Trop (Mars); 1992; 52(1):63-6. PubMed ID: 1602955 [TBL] [Abstract][Full Text] [Related]
30. Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies. Mittelman M; Zeidman A; Kanter P; Katz O; Oster H; Rund D; Neumann D Eur J Haematol; 2004 Mar; 72(3):155-65. PubMed ID: 14962233 [TBL] [Abstract][Full Text] [Related]
31. [The role of homeostatic function of the kidneys in the development of hyperuricemia]. Karvé MD; Shamarin VM; Vinogradova IV; Kiseleva NS; Ankhimiuk ON Nauchnye Doki Vyss Shkoly Biol Nauki; 1989; (12):54-9. PubMed ID: 2624846 [TBL] [Abstract][Full Text] [Related]
32. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452 [TBL] [Abstract][Full Text] [Related]
33. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children. Tumgor G; Arikan C; Kilic M; Aydogdu S Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488 [TBL] [Abstract][Full Text] [Related]
34. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Hungria VT; Latrilha MC; Rodrigues DG; Bydlowski SP; Chiattone CS; Maranhão RC Cancer Chemother Pharmacol; 2004 Jan; 53(1):51-60. PubMed ID: 14574458 [TBL] [Abstract][Full Text] [Related]
35. [Cytogenetical and clinico-hematological changes in myeloma disease]. Dubrova SE; Dygin VP; Ushakova EA Tsitologiia; 1966; 8(2):241-9. PubMed ID: 5984072 [No Abstract] [Full Text] [Related]